Radiation immunodynamics in patients with glioblastoma receiving chemoradiation.

ABSTRACT:

Introduction

This is a prospective, rigorous inquiry into the systemic immune effects of standard adjuvant chemoradiotherapy, for WHO grade 4, glioblastoma. The purpose is to identify peripheral immunologic effects never yet reported in key immune populations, including myeloid-derived suppressor cells, which are critical to the immune suppressive environment of glioblastoma. We hypothesize that harmful immune-supportive white blood cells, myeloid derived suppressor cells, expand in response to conventionally fractionated radiotherapy with concurrent temozolomide, essentially promoting systemic immunity similar what is seen in chronic diseases like diabetes and heart disease.

Methods

16 patients were enrolled in a single-institution, observational, immune surveillance study

SUBMITTER: Sloan L 

PROVIDER: S-EPMC11427284 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature